Khursheed Anwer
Hoofd Techniek/Wetenschap/O&O bij IMUNON, INC.
Vermogen: 4 111 $ op 31-05-2024
Oorsprong van het eerstegraads netwerk van Khursheed Anwer
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
20
| Public Company | Biotechnology | 20 |
Egen, Inc.
 Egen, Inc. Medical SpecialtiesHealth Technology Egen, Inc. operates as a clinical stage biopharmaceutical company which develops novel proprietary nanoparticle delivery technology for therapeutic use. Egen's technology platform is very broad, including polymer, cationic lipid, and molecular biology-based approaches to delivery of nucleic acid and anti-cancer drugs. The primary activities of the company are the application of the TheraPlas and TheraSilence platforms to the treatment of human disease. Egen's lead candidate, EGEN-001, is in Phase II clinical testing for ovarian cancer and in Phase I clinical testing for colorectal cancer. In addition, Egen is pursuing pre-clinical development of its TheraSilence RNAi delivery program for multiple disease applications, as well as other novel disruptive technologies focused on creating the next generation of synthetic nanoparticle delivery systems and nucleic acid-based therapies. It is also active in pursuing partnerships and working with external collaborators to further develop its delivery technology for multiple applications. Egen offers cutting-edge research services relating to non-viral polymeric gene carrier systems, and other approaches for the delivery of nucleic acid and anti-cancer drugs. The company's synthetic biocompatible delivery vehicles can be used to deliver therapeutic genes, inhibitory RNA (RNAi), and small molecules by protecting the therapeutic cargo from degradation, promoting uptake by target cells, and facilitating intracellular trafficking. Egen was founded in 2002 by Sung Wan Kim and is headquartered in Huntsville, AL.
3
| Extinct | Medical Specialties | 3 |
Valentis, Inc.
 Valentis, Inc. Pharmaceuticals: MajorHealth Technology Valentis lead drug candidate, Deltavasc, may treat peripheral arterial and ischemic heart disease with a gene that spurs new blood vessels to form (a process known as angiogenesis). In early stages of development are DNA vaccines for HIV, hepatitis C, and other viral infections. Another drug candidate, eNOS, could prevent tissue rejection in transplant recipients. The company licenses its technology -- include the GeneSwitch platform, which can turn off or on gene therapies -- to other drugmakers. These licensees include Genzyme, Pfizer, and GlaxoSmithKline.
3
| Extinct | Pharmaceuticals: Major | 3 |
Culverhouse College of Commerce
3
| College/University | Other Consumer Services | 3 |
gMed., Inc.
 gMed., Inc. BiotechnologyHealth Technology gMed is engaged in providing physicians with information solutions to “Care Better” for their patients and practice. The company provides Digital Charting solutions for Gastroenterology and Cardiology designed to eliminate paper, increase revenues, decrease costs and enhance patient care at the medical office, ambulatory surgery center and hosptial. gMED was founded in 1997 and is located in Weston, FL.
1
| Extinct | Biotechnology | 1 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Khursheed Anwer via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| Harvard Business School | College/University | Undergraduate Degree Masters Business Admin Masters Business Admin | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Songbird Holdings LLC
 Songbird Holdings LLC Medical SpecialtiesHealth Technology Songbird Holdings LLC designs and manufactures hearing devices. Its products include songbird ultra, songbird ultra 2.0 replacement batteries, 2-pack ultra 2.0 right ear assembly and songbird air. The firm offers its products online, as well as through retailers. Songbird makes it as easy as buying a pair of new reading glasses. It provides a strong alternative to traditional hearing aids that can cost thousands of dollars. The company was founded in 2000 by Frederick J. Fritz and is headquartered in Tulsa, OK. | Medical Specialties | Chief Executive Officer Corporate Officer/Principal | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| INSEAD | College/University | Masters Business Admin Masters Business Admin | |
| BIOGEN INC. | Pharmaceuticals: Major | Comptroller/Controller/Auditor Corporate Officer/Principal | |
| ABBOTT LABORATORIES | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal | |
Slone Career Strategies, Inc.
 Slone Career Strategies, Inc. Personnel ServicesCommercial Services Slone Career Strategies, Inc. engages in delivering executive, management, and sales talent for the diagnostic laboratory industry. The company was founded by Adam Slone in 2000 and is headquartered in South Riding, VA. | Personnel Services | Director/Board Member Director/Board Member | |
| ALLIED GROUP LIMITED | Finance/Rental/Leasing | Chief Executive Officer | |
| The University of Alabama | College/University | Doctorate Degree | |
The Controlled Release Society
 The Controlled Release Society Miscellaneous Commercial ServicesCommercial Services The Controlled Release Society is a private company that focuses on providing fundamental delivery research, development, regulatory science, and clinical translation. The company is based in St. Paul, MN. The company was founded by Agis Kydonieus. | Miscellaneous Commercial Services | President | |
Lewis Consulting, Inc.
 Lewis Consulting, Inc. Pharmaceuticals: MajorHealth Technology Lewis Consulting, Inc. provides pharmaceutical services. The private company is based in Raleigh, NC. | Pharmaceuticals: Major | President | |
| Florida State University | College/University | Doctorate Degree | |
| London Business School | College/University | Graduate Degree | |
| Technology Innovations LLC | Corporate Officer/Principal | ||
| Association of Corporate Growth | Corporate Officer/Principal | ||
| University of South Australia | College/University | Doctorate Degree | |
| COCOON HOLDINGS LIMITED | Financial Conglomerates | Chief Executive Officer | |
| Pacific Life Science Holdings Ltd. | Chief Executive Officer | ||
| AUTOMOTIVE FINCO CORP. | Finance/Rental/Leasing | Director/Board Member | |
| HHG CAPITAL CORPORATION | Financial Conglomerates | Director/Board Member | |
| KAISUN HOLDINGS LIMITED | Coal | Compliance Officer | |
| Delphinium Female Leadership Fund Ltd. | Director/Board Member | ||
| Sino Path Consultants Ltd. | Director/Board Member | ||
| University of North Alabama | College/University | Undergraduate Degree | |
| MEDIFOCUS, INC. | Medical Specialties | Director/Board Member | |
| City University of Hong Kong | College/University | Doctorate Degree | |
Aerami Therapeutics, Inc.
 Aerami Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Aerami Therapeutics, Inc. develops inhaled insulin products to treat diabetes patients. Its product Dance 501 is designed to produce consistently sized particles of liquid insulin in the form of a smooth mist, allowing the efficient and consistent delivery of insulin into the lungs in a few comfortable breaths. The company was founded by John Stuart Patton in February 9, 2009 and is headquartered in Durham, NC. | Pharmaceuticals: Major | Director/Board Member | |
Ocean Capital Acquisition Corp.
 Ocean Capital Acquisition Corp. Financial ConglomeratesFinance Ocean Capital Acquisition Corp. operates as a blank check company. It is incorporated in the British Virgin Islands as a business company with limited liability for the purpose of effecting into a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or similar business combination with one or more businesses or entities. The company was founded on August 20, 2021 and is headquartered in Singapore. | Financial Conglomerates | Director/Board Member | |
| Harmony Asset Management Ltd. | Chairman | ||
| Gwynneth Gold Ltd. | Director/Board Member | ||
| REAL NUTRICEUTICAL GROUP LIMITED | Pharmaceuticals: Other | Director/Board Member | |
| JIAN EPAYMENT SYSTEMS LIMITED | Electronic Equipment/Instruments | Director/Board Member | |
Dendrite International, Inc.
 Dendrite International, Inc. Packaged SoftwareTechnology Services Dendrite International, Inc. provides sales force software products and support services. It offers technological tools, databases, and data flow management services. The company provides services to the pharmaceutical, life sciences, and healthcare industries. Dendrite International was founded by John E. Bailye in 1986 and is headquartered in Bedminster, NJ. | Packaged Software | General Counsel | |
PR Pharmaceuticals, Inc.
 PR Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology PR Pharmaceuticals, Inc. develops, manufactures and commercialization of bioactive compounds in sustained-release formulations. It offers injectable and biodegradable formulations to treat chronic diseases. It produces drug delivery technologies for human and animal health. Its products include Insular, Pulmolar, and Somalar. The company was founded in 1998 by Steve R. Howe & William R. Lance and is located in Fort Collins, CO | Pharmaceuticals: Major | Director/Board Member | |
| Boston College | College/University | Undergraduate Degree | |
CSL Behring LLC
 CSL Behring LLC BiotechnologyHealth Technology CSL Behring LLC researches, develops, manufactures, and markets biotherapies that are used to treat serious and rare conditions. It offers protein-based therapies in the areas of Bleeding Disorders, Fluid Replacement, Hereditary Angioedema, Immunoglobulin, Pulmonary, and Wound Healing Therapies. The company was founded in 2004 and is headquartered in King of Prussia, PA. | Biotechnology | Chief Operating Officer | |
| Aventis Behring LLC | Corporate Officer/Principal | ||
Aventis Bio-Services, Inc.
 Aventis Bio-Services, Inc. Pharmaceuticals: MajorHealth Technology Part of Sanofi, Aventis Bio-Services, Inc. develops pharmaceutical and agricultural products. The company is based in King of Prussia, PA. | Pharmaceuticals: Major | President | |
Taiho Pharmaceutical Co., Ltd.
 Taiho Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Taiho Pharmaceutical Co., Ltd. engages in the production of drugs and medical products. It researches, innovates, and develops pharmaceuticals for various diseases. The company was founded on June 1, 1963 and is headquartered in Tokyo, Japan. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Jazz Pharmaceuticals (EUSA Pharma USA), Inc.
 Jazz Pharmaceuticals (EUSA Pharma USA), Inc. BiotechnologyHealth Technology Jazz Pharmaceuticals (EUSA Pharma USA), Inc. develops and markets biopharmaceutical products. The company was founded on November 7, 1980 and is headquartered in Princeton, NJ. | Biotechnology | Corporate Officer/Principal | |
Anthra Pharmaceuticals, Inc.
 Anthra Pharmaceuticals, Inc. Medical DistributorsDistribution Services Anthra Pharmaceuticals, Inc. is an American company. | Medical Distributors | Corporate Officer/Principal | |
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Biotechnology | Corporate Officer/Principal | |
| American University of The Caribbean School of Medicine | College/University | Doctorate Degree | |
| Rutgers State University of New Jersey | College/University | Undergraduate Degree | |
| AMICUS THERAPEUTICS, INC. | Pharmaceuticals: Major | Director of Finance/CFO | |
| E I DU PONT DE NEMOURS AND CO | Chemicals: Agricultural | Corporate Officer/Principal | |
Southern BioSystems, Inc.
 Southern BioSystems, Inc. Medical SpecialtiesHealth Technology Part of DURECT Corp., Southern BioSystems, Inc. is a company that manufactures and develops biodegradable polymer and non-polymer drug delivery systems. The company is based in Birmingham, AL. The company was founded by Alan H. Dean. Southern BioSystems was acquired by DURECT Corp. on April 30, 2001 for $13.64 million. | Medical Specialties | Director/Board Member | |
| VALERITAS INC | Medical Specialties | Director of Finance/CFO |
Statistieken
Internationaal
| Verenigde Staten | 32 |
| Hongkong | 9 |
| Frankrijk | 3 |
| Canada | 3 |
| Singapore | 3 |
Sectoraal
| Health Technology | 19 |
| Consumer Services | 12 |
| Finance | 6 |
| Commercial Services | 3 |
| Energy Minerals | 2 |
Operationeel
| Director/Board Member | 81 |
| Corporate Officer/Principal | 76 |
| President | 29 |
| Independent Dir/Board Member | 27 |
| Chief Executive Officer | 27 |
Sterkste connecties
| Insiders | |
|---|---|
| Daryl Byrd | 34 |
| Max E. Link | 28 |
| Christine Pellizzari | 22 |
| Corinne Le Goff | 19 |
| Pok Yu Chow | 19 |
| Gregory M. McKee | 12 |
| Frederick Fritz | 11 |
| Andreas Voss | 11 |
| Ben McGraw | 11 |
| Richard Waldron | 9 |
| James Dentzer | 9 |
| Michael Tardugno | 9 |
| Danny H. Lewis | 9 |
| Donald Braun | 8 |
| Jeffrey Church | 8 |
- Beurs
- Insiders
- Khursheed Anwer
- Bedrijfsconnecties
